BioSpectrum Asia - October 2016Add to Favorites

Get BioSpectrum Asia along with 5,000+ other magazines & newspapers

Try FREE for 7 days

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.

1 Year$99.99

bookLatest and past issues of 5,000+ magazines & newspapersphoneDigital Access. Cancel Anytime.familyShare with 4 family members.
(Or)

Get BioSpectrum Asia

1 Year $10.99

book12 issues starting from BioSpectrum Asia August 2021 phoneDigital Access. Cancel Anytime.

Gift BioSpectrum Asia

  • Magazine Details
  • In this issue

Magazine Description

In this issue

Central Nervous System (cNS) disorder is a rising burden on global healthcare economy but has not attracted the same attention by investors, researchers and pharmaceutical companies as other chronic diseases mostly because of the high risk involved in the associated drug development� cNS diseases are widely categorized into psychiatry that includes anxiety, depression, bipolar disorders, schizophrenia and aDHD (attention deficit hyperactivity disorder); neurology that covers migraine, epilepsy, parkinson’s disease, multiple sclerosis, narcolepsy and alzheimer’s disease; and pain related to cNS disorders.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
RECENT STORIES FROM BIOSPECTRUM ASIAView All